Viewing Study NCT02195505


Ignite Creation Date: 2025-12-25 @ 3:19 AM
Ignite Modification Date: 2026-02-25 @ 9:49 PM
Study NCT ID: NCT02195505
Status: COMPLETED
Last Update Posted: 2014-07-21
First Post: 2014-07-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Use of Synvisc® in Knee Osteoarthritis - Medico-economical Study
Sponsor: Boehringer Ingelheim
Organization:

Study Overview

Official Title: Use of Synvisc® in Knee Osteoarthritis - Medico-economical Study (U.S.A.G.E. Médico-Economique)
Status: COMPLETED
Status Verified Date: 2014-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The USAGE study aims at assessing on a long-term period (two years in average) the outcome in clinical or economical term of patients with knee osteoarthritis (OA) treated or not with Synvisc®, in the 1139.4 clinical trial.
Detailed Description: None

Study Oversight

Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: